Revisiting COX-2 inhibitors for Alzheimer's disease as multitargeted ligands: Development of 4-hydrazono-pyrazolidinediones with tuned COX selectivity profile and improved cellular potency. - Waheed R; Mostafa Z; Emad M; Darwish SS; Purgatorio R; Miniero DV; De Palma A; Cheng TP; Wang TY; Chen YC; El Kerdawy AM; Gabr M; et al. (European journal of medicinal chemistry, 2026)